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Flavivirus infection induces endoplasmic reticu-
lum (ER) membrane rearrangements to generate a
compartment for replication of the viral genome
and assembly of viral particles. Using quantitative
mass spectrometry, we identified several ESCRT
(endosomal sorting complex required for transport)
proteins that are recruited to sites of virus replication
on the ER. Systematic small interfering RNA (siRNA)
screening revealed that release of both dengue virus
and Japanese encephalitis virus was dramatically
decreased by single depletion of TSG101 or co-
depletion of specific combinations of ESCRT-III pro-
teins, resulting in R1,000-fold titer reductions. By
contrast, release was unaffected by depletion of
some core ESCRTs, including VPS4. Reintroduction
of ESCRT proteins to siRNA-depleted cells revealed
interactions among ESCRT proteins that are crucial
for flavivirus budding. Electron-microscopy studies
revealed that the CHMP2 and CHMP4 proteins func-
tion directly in membrane deformation at the ER.
Thus, a unique and specific subset of ESCRT contrib-
utes to ER membrane biogenesis during flavivirus
infection.INTRODUCTION
Flaviviruses are members of the single-stranded, positive-sense
RNA (ssRNA(+)) viruses. This family of viruses includes dengue
virus (DENV) and Japanese encephalitis virus (JEV), which cause
large epidemics and tens of thousands of deaths annually in
many parts of the world (Gould and Solomon, 2008). Virus as-Cell Re
This is an open access article under the CC BY-Nsembly is a highly conserved process in viral life cycles, and,
therefore, it represents a promising target for broad-spectrum
antiviral therapies. For many enveloped viruses, viral particle for-
mation requires recruitment of machinery normally involved in
two analogous cellular membrane fission events, formation of
small vesicles into multivesicular bodies (MVBs) and abscission
during cytokinesis (McCullough et al., 2013). This machinery,
whose components are called the endosomal sorting complex
required for transport (ESCRT), functions on the plasma mem-
brane or endosome to induce deformation of membranes away
from the cytoplasm, and, ultimately, it pinches off of viral parti-
cles from the cell membrane (Hurley and Hanson, 2010).
Flaviviruses are replicated and assembled at the endoplasmic
reticulum (ER), concomitant with dramatic rearrangement of
membrane structure, to generate a specific compartment gener-
ally referred to as the viral replication organelle (Welsch et al.,
2009). During viral genome replication, viruses produce small
compartments in the ER lumen associated with the formation
of vesicles whose outer membranes are connected to the ER
via a neck-like structure. The newly synthesized genome is
assembled on the ER membrane and buds into the ER lumen
(Chatel-Chaix and Bartenschlager, 2014). This budding process
is driven by the viral structural proteins prM and E. Recent
studies revealed that NS2A and NS3, viral non-structural pro-
teins, also play essential roles in this process (Carpp et al.,
2011; Chiou et al., 2003), although their mechanistic roles have
not been elucidated.
TheESCRTpathway isconserved inall eukaryotesandconsists
of several distinct heteromeric complexes that are sequentially re-
cruited to sites of membrane deformation. ESCRT-0 recognizes
ubiquitylated cargo; ESCRT-I, ESCRT-II, and ALIX play roles in
the concentration of cargoes and deformation of membranes;
andESCRT-III constitutes the fissionmachinery.Mammaliancells
express 12 ESCRT-III proteins, designated charged MVB protein
(CHMP), which form at least two subcomplexes consisting of
the CHMP6–CHMP4 family (A–C) and theCHMP3–CHMP2 familyports 16, 2339–2347, August 30, 2016 ª 2016 The Author(s). 2339
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Requirements for ESCRT Proteins in Flavivirus Prop-
agation
(A and B) JEV titers (A) or DENV titers (B) in supernatants from 293A cells
treated with the indicated siRNAs. After 72 hr (for JEV) or 96 hr (for DENV), viral
titers were measured by focus-forming assay.
(C) Phenotype rescue by exogenous expression of ESCRT proteins. Plasmids
expressing various ESCRT proteins with siRNA-resistant silent mutations were
co-transfected with siRNAs and monitored for phenotype rescue by the
measurement of viral infectivity (left panels). Protein expression levels in cell
lysates were measured by western blotting (right panels). Numbers in paren-
theses indicate the positions of siRNA target sequences.
*p < 0.05 and **p < 0.01 relative to control-1; ns, non-significant.
2340 Cell Reports 16, 2339–2347, August 30, 2016(A and B). CHMP6, an early acting ESCRT-III that directly binds
ESCRT-II, recruits a member of the CHMP4 family, which in turn
recruits CHMP3 followed by a member of the CHMP2 family,
thereby forming a large ESCRT-III spiraling-helical core complex
that can deform membranes (Henne et al., 2011). Other ESCRT-
III family members (CHMP1A, B, CHMP5, CHMP7, and IST1)
appear to play regulatory roles in this process. Membrane defor-
mation is followedby the recruitment of VPS4ATPasecomplexes,
which function in the disassembly and recycling of all ESCRT fac-
tors (Henne et al., 2011). In mammalian cells, nearly 40 ESCRT
proteins have been identified. However, only specific subsets of
these factors are sufficient to complete each ESCRT-mediated
process. For example, among the 12 ESCRT-III proteins, HIV-1
budding requires only the CHMP2 and CHMP4 proteins, whereas
MVB vesicle formation requires CHMP6 and CHMP3 proteins as
well (Morita et al., 2011).
In this study, we purified viral replication organelles and found
that several ESCRT factors are recruited to the site of virus
assembly on the ER membrane. We investigated the specific
requirement for ESCRT components in flavivirus infection by
performing systematic small interfering RNA (siRNA) knockdown
screening. The results revealed that a unique set of ESCRT com-
ponents functions directly in membrane deformation during for-
mation of the viral particle, but not formation of the replication
compartment, on the ER membrane.
RESULTS
Requirement for ESCRT Factors in Flavivirus
Propagation
To identify cellular factors recruited to the replication organelles
during viral propagation, we performed stable isotope labeling
using amino acids in cell culture (SILAC)-based quantitative
mass spectrometry analysis (the detailed method is described
in the Supplemental Experimental Procedures). Based on these
analyses, we identified CHMP4B and ALIX as factors that accu-
mulate in replication organelle-enriched fractions in JEV-in-
fected cells (Figures S1A–S1D; Table S1).
To evaluate the importance of the ESCRT pathway, we first
individually depleted each ESCRT factor and monitored flavivi-
rus propagation. Each siRNA efficiently depleted its endogenous
target protein without any cell toxicity (Figures S2 and S3) (Morita
et al., 2010, 2011). The screen revealed that TSG101 depletion
strongly inhibited viral propagation (10-fold reduction in JEV titer
and 1,000-fold reduction in DENV titer versus control siRNA
treatment) (Figures 1A and 1B, compare lane 11 to lanes 1
Figure 2. ESCRT Depletions Impair Virus
Production
(A) Effect of ESCRT knockdowns on virus pro-
duction in viral RNA genome transfection experi-
ments. Knockdown cells were transfected withWT
or replication-competent mutant (GND) JEV RNA,
and viral titers were determined at 0, 24, 48, and
72 hr post-transfection.
(B) Effect of ESCRT knockdown on production of
JEV SRIP. Plasmid expressing sub-genomic re-
plicon RNA and structural proteins, shown in the
upper panels, were co-transfected with control or
ESCRT siRNAs. At 72 hr after transfection, the
infectivity of SRIPs was measured by counting
NS3-positive cells after secondary infection to the
Vero cells (lower left), and protein expression levels
were measured by western blotting (lower right).
*p < 0.05 and **p < 0.01 relative to control siRNA.and 2), although the majority of single depletions of other ESCRT
factors, including the CHMP family and VPS4, exerted no or
moderate effects on both JEV and DENV virus propagation.
The reduction of both JEV and DENV infectivity in TSG101-
depleted cells was rescued by exogenous expression of
TSG101 with silent mutations in the siRNA target sequence,
excluding the possibility of siRNA off-target effects (Figures 1C
and S3D). These results indicate that at least TSG101 plays an
essential role in flavivirus replication.
We next investigated the possibility of functional redundancy.
We analyzed the effects of simultaneously depleting multiple
members of each family: CHMP1 (CHMP1A and 1B), CHMP2
(CHMP2A and 2B), CHMP4 (CHMP4A, 4B, and 4C), and VPS4
(VPS4A and 4B). Because the CHMP2 and CHMP3 proteins
can form helical polymers in the same complex (Effantin et al.,
2013), we also tested simultaneous depletion of CHMP2A, 2B,
and 3. Single depletion or co-depletion of CHMP2A and
CHMP2B resulted in modest effects, but the additional depletion
of CHMP3 caused dramatic reductions in flavivirus propagation
(14-fold reduction in JEV titer and 1,800-fold reduction in DENV
titer versus control siRNA treatment) (Figures 1A and 1B,
compare lanes 13 and 14 to lanes 1 and 2). Similar results
were observed for the CHMP4 family proteins. Co-depletion of
either CHMP4A and CHMP4B or CHMP4B and CHMP4C
dramatically reduced flavivirus propagation (Figures 1A and
1B, compare lanes 15–17 to lanes 1 and 2). However, the addi-
tional depletion of CHMP4C resulted in a further reduction of
virus titer relative to the double depletions (Figures 1A and 1B,
compare lanes 15–17 to lane 18). This phenotype was rescued
by exogenous expression of individual ESCRT-III proteins (Fig-
ures 1C and S3D). These data imply that individual CHMP2/3
and CHMP4 family members function redundantly and that repli-
cation of both JEV and DENV requires the presence of at least
one CHMP2/3 family member and at least one CHMP4 family
member in addition to TSG101.
The ESCRT Pathway Is Essential for the Late Stage of
Viral Infection
To determine which stage of flavivirus infection was impaired
by the ESCRT depletions, we tested the effects of ESCRT deple-tions on each viral replication step. To rule out the viral entry step,
we first tested the effect of an siRNA using a viral genomic RNA
transfection system. In-vitro-transcribed JEV genomic RNA was
co-transfected with siRNAs targeting TSG101, the CHMP2/3
family, or the CHMP4 family, and extracellular viral infectivity
was measured. At 24 and 48 hr post-transfection, a significant
amount of infectious particles was detected in the control
siRNA-transfected cell, but not in the replication-deficient GND
mutant control. Likewise, very low or undetectable amounts of
infectious particles were released from TSG101-, CHMP2/3-,
or CHMP4-depleted cells, although an equal number of cells ex-
pressed viral structural proteins (Figures 2A, S3E, and S3F).
These results indicate that the ESCRT pathway is required at
least in the late stage of infection.
Next we tested the effects against the viral sub-genomic re-
plicon system. In these experiments, we transfected cells with
viral sub-genomic RNA in which the structural protein-coding
region was absent from the viral genome. Depletion of
TSG101, the CHMP2/3 family, or the CHMP4 family had no ef-
fect on viral non-structural protein expression or viral genome
RNA level in transfected cells (Figures S3G and S3H). These
results suggest that the ESCRT pathway does not play an
essential role in genomic RNA replication. When viral struc-
tural proteins were supplied in trans into the sub-genomic re-
plicon cells, single-round infectious particles (SRIPs) were
released from the cells (Suzuki et al., 2014). The infectivity
of SRIPs produced from TSG101-, CHMP2/3-, or CHMP4-
depleted cells was significantly decreased relative to control
cells (Figure 2B). These results suggest that the ESCRT
pathway plays an important role in the viral assembly and/or
budding step.
ESCRT Factors Are Required for Flavivirus Particle
Formation on the ER Membrane
The ESCRT pathway is involved in the membrane budding from
the cytoplasmic face toward the outside of the cell. At the late
stage of flaviviral infection, there are two similar membrane
deformation events on the ER membrane: formation of the viral
replication compartment and formation of the viral particle.
Both events are accompanied by membrane budding into theCell Reports 16, 2339–2347, August 30, 2016 2341
Figure 3. ESCRTProteins Are Involved in ER
Membrane Deformation during Viral Particle
Formation
(A) Ultrastructure of viral particle formation sites in
cells treated with control siRNA, CHMP2/3 siRNA,
or CHMP4 siRNA, as determined by CLEM anal-
ysis. After detection of anti-JEV NS3 (green) and
anti-dsRNA (magenta) antibody-positive struc-
tures by confocal fluorescent microscopy (left
panels), ultra-thin-sectioned images were ob-
tained by electron microscopy (middle panels,
merged with fluorescent images). Magnified im-
ages are shown in right panels. Yellow arrowheads
indicate virions (Vi).
(B) Number of mature virions at viral replication
sites. The number of virions per 1 mm2 of NS3- and
dsRNA-positive area was counted.
(C) Frequency of membrane-associated virions.
Membrane-associated virions (yellow arrowheads)
were counted and shown as percentages of total
virions.
*p < 0.01 and **p < 0.05 relative to control siRNA.
Data in (B) and (C) come from more than three
different cells.ER lumen away from the cytoplasmic face (Chatel-Chaix and
Bartenschlager, 2014).
To determine which membrane deformation event was
impaired in ESCRT-depleted cells, we performed correlative
light microscopy-electron microscopy (CLEM) analysis. After
co-staining with anti-JEV NS3 and anti-double-stranded RNA
(dsRNA) antibodies, we observed a viral replication organelle
by fluorescent confocal microscopy. The same cells were
then ultra-thin-sectioned and stained with heavy metals, and
the ultrastructure of the antibody-positive compartment was
observed by electron microscopy. In control siRNA-trans-
fected cells, vesicle packets (VPs), convoluted membrane
(CM), and viral particles were observed in the NS3- and
dsRNA-positive structures, which co-localized with an ER
marker (Figures 3A, S1E, and S1F). On the other hand, the
number of viral particles was significantly reduced in cells
depleted in CHMP2/3- or CHMP4-deleted cells, although there
were no significant differences in the structures of VPs and
CM (Figures 3A and 3B). Furthermore, the number of mem-
brane-associated incomplete viral particle-like structures was
elevated in ESCRT-depleted cells (Figures 3A and 3C). These
results suggest that ESCRT deficiency induces the arrest
of viral budding rather than formation of the replication
compartment.
To investigate the direct involvement of the ESCRT pathway
in viral particle formation, we performed immunoelectron micro-
scopic analysis using anti-ESCRT-III antibodies. Antibodies
recognizing endogenous CHMP2B and CHMP4B stained the
viral replication organelle in JEV-infected cells (Figure 4). As
shown in Figure 5, both anti-CHMP2B and anti-CHMP4A anti-
bodies were detected adjacent to viral particles, rather than
in small vesicles in VPs, and these signals were proximal to
anti-JEV E antibodies (Figures 5 and S1G). These results sug-
gest that the ESCRT pathway may be directly involved in
membrane deformation inside the neck during viral particle
formation.2342 Cell Reports 16, 2339–2347, August 30, 2016Importance of ESCRT-III-Binding Factors on Flavivirus
Replication
The ESCRT pathway is involved in membrane fission events at
various cytoplasmic locations. However, the requirement of
ESCRT factors is varied in each event and/or location (Morita,
2012). To identify the specific requirement for ESCRTs in flavivi-
rus budding on the ER membrane, we evaluated the importance
of ESCRT-binding factors in functional rescue assays using
various ESCRT mutants. TSG101 interacts with ubiquitin and
PT(/S)AP late domain to facilitate MVB vesicle formation and
retrovirus budding (Pornillos et al., 2002), and it also interacts
with CEP55 in cytokinesis (Carlton and Martin-Serrano, 2007;
Morita et al., 2007). As shown in Figures 1C and 6A, reintroduc-
tion of wild-type (WT) TSG101 rescued JEV growth. Similar
functional rescue was observed with ubiquitin- or CEP55-bind-
ing-deficient mutants of TSG101. However, a PT(/S)AP-bind-
ing-deficient mutant of TSG101 did not rescue JEV growth
(Figure 6A). These results indicate that binding of TSG101 to
PT(/S)AP, but not other partners, is critical for JEV production.
Similar experiments were performed in ESCRT-III-depleted
cells. Expression of WT CHMP2A rescued the impairment of
JEV growth caused by CHMP2A, CHMP2B, or CHMP3 deple-
tion; however, amutant lacking the eight N-terminal amino acids,
which has deficiencies in membrane binding (Buchkovich et al.,
2013), did not completely rescue JEV growth, suggesting that
membrane anchoring of CHMP2A is required for viral propaga-
tion (Figure 6B). A previous study showed that alanine substitu-
tion of R24, R27, and R31 in CHMP2A (denoted as CHMP4)
disrupts its binding to CHMP4 family proteins (Morita et al.,
2011). Expression of a CHMP4-binding-deficient mutant of
CHMP2A did not completely rescue JEV growth in CHMP2/3-
depleted cells (Figure 6B), suggesting that the CHMP4-binding
activity of CHMP2A is important for viral propagation. Next we
tested the importance of the VPS4-binding activity of CHMP2A.
Mutations at L216D and L219D in theMIT-interactingmotif (MIM)
of CHMP2A (denoted as VPS4) disrupt its ability to bind theMIT
Figure 4. Endogenous CHMP2B and CHMP4A Are Localized at Viral Replication Site in Virus-Infected Cells
(A) Mock- (lane 1) and JEV-infected (lanes 2–4) Vero cells at 48 hr post-infection were fixed by 4% paraformaldehyde, and they were co-stained with anti-
CHMP2B antibody (upper panels, green) or anti-CHMP4B antibody (lower panels, green) with anti-JEV E antibody (magenta). Single confocal slice images were
obtained from confocal laser-scanning microscopy. Scale bars represent 10 mm.
(B) Signal intensities on the white arrows in (A) were measured and shown as green (CHMP2B or CHMP4A) and magenta (JEV E).domains of both VPS4A and VPS4B, and they cause defects in
MVB sorting and HIV budding (Stuchell-Brereton et al., 2007).
Surprisingly, expression of a VPS4-binding-deficient mutant of
CHMP2A fully rescued the JEV growth (Figure 6B). These results
are consistent with the observation that co-depletion of VPS4A
and VPS4B did not affect flavivirus growth (Figures 1A and 1B),
and they raise the possibility that the VPS4-binding activity of
CHMP2A is not essential for viral propagation.
We conducted similar experiments with the CHMP4 family
of proteins. Exogenous expression of WT CHMP4A, CHMP4B,
or CHMP4C rescued the JEV growth impairment phenotype
in CHMP4A/CHMP4B/CHMP4C triple-depleted cells (Figures
6C–6E), although, in the case of CHMP4C, we could not make
a strict comparison to physiological condition due to our failure
to detect endogenous CHMP4C. In the case of CHMP4A
or CHMP4C, but not CHMP4B, membrane binding-deficient
mutants (denoted as F8E) (Buchkovich et al., 2013) did not
completely rescue growth, indicating that membrane associa-
tion of at least CHMP4A or CHMP4C is important for virus
infection.
Next we tested for ALIX-binding activity. Alanine substitution
of L260 in CHMP4A, L217 in CHMP4B, or L228 in CHMP4C (all
mutants denoted as ALIX in Figures 6C–6E) disrupts binding
of the respective proteins to ALIX (McCullough et al., 2008). As
shown in Figure 6, all ALIX binding-deficient mutants completely
rescued JEV growth. Those results are consistent with the fact
that ALIX depletion did not affect flavivirus growth (Figures 1A
and 1B), and they suggested that ALIX-binding activities of
CHMP4 proteins are not essential for viral propagation. More-
over, a CHMP4Bmutant that does not bind to CC2D1A (denoted
as CC2D1A) (Martinelli et al., 2012) rescued JEV growth only
partially (Figure 6D). These results suggest that the CC2D1A-
binding activity of CHMP4B may play roles in virus propagation.
However, the expression of CHMP4C with a mutation at serine
120, which is phosphorylated during cell division (Carlton et al.,2012), rescued to the same extent as WT (Figure 6E), indicating
that the phosphorylation of S120 is not critical for viral propaga-
tion. Taken together, these data demonstrate that flavivirus
particle formation is driven by specific subfamilies of ESCRT fac-
tors and may not require certain essential ESCRT components,
such as the VPS4 family of proteins.
DISCUSSION
In this study, we identified several ESCRT proteins as factors that
are recruited to the viral replication organelle in JEV-infected
cells and function in viral particle formation on the ERmembrane.
Our results show that flaviviruses, like other RNA viruses, usurp
the cellular machinery for MVB vesicle formation to generate
their own envelopes. ESCRT factors primarily function on the en-
dosomal membrane, plasma membrane, or midbodies (Hurley
et al., 2010); however, our results strongly suggest that they
are also involved in ER membrane biogenesis. Recently, two in-
dependent groups reported that the ESCRT pathway plays an
important role in re-assembly of the nuclear envelope during
cell division (Olmos et al., 2015; Vietri et al., 2015). Early electron
microscopy imaging studies revealed that the nuclear envelope
is continuous with the ER membrane and absorbed by the ER
membrane during mitosis (Porter and MacHado, 1960). There-
fore, it is not surprising that the ESCRT pathway is directly
involved in membrane deformation on the ER. To date, there
has been no clear observation of ER vesicle formation that
accompanies membrane invagination toward the lumen under
physiological conditions. However, it is possible that the ESCRT
pathway may be involved in luminal vesicle formation on the
ER under particular circumstances, such as the formation of
granulovacuolar degeneration seen in neurons from Alzheimer’s
disease patients (Yamazaki et al., 2010).
Recently, two independent groups revealed that yeast
models of positive-strand RNA viruses, tomato bushy stuntCell Reports 16, 2339–2347, August 30, 2016 2343
Figure 5. Immunoelectron Microscopic
Analysis of CHMP2B and CHMP4A in JEV-
Infected Cells
At 48 hr after JEV infection, Vero cells were fixed
and reacted with antibodies specific for CHMP2B
(left) or CHMP4A (right). The enhanced signals
for CHMP2B and CHMP4A are represented by
white arrowheads. Black arrowheads indicate
small vesicles (Ve). The small gray electron-dense
spherical structures correspond to virions (Vi,
white arrows).tombusvirus (TBSV) and brome mosaic virus (BMV), require the
ESCRT factors for the replication compartment formation (Bar-
ajas et al., 2009; Diaz et al., 2015). However, our study demon-
strated that ESCRT depletion results in neither morphological
changes in the formation of the replication compartment nor
impairment of flaviviral genome replication, suggesting that
the stage when ESCRT is necessary is different from the
case of TBSV or BMV. Similar results were reported in the hep-
atitis C virus (HCV), which also utilizes the ESCRT pathway
solely for the formation of viral particles and not for the forma-
tion of the replication compartment (Corless et al., 2010).
Furthermore, a recent report showed that the hepatitis A virus
(HAV), a pathogenic picornavirus and non-enveloped ssRNA(+)
virus that forms its replication vesicle compartment on the ER
membrane, does not utilize the ESCRT pathway for genome
RNA replication, although the ESCRT pathway is necessary
for release from the cells (Feng et al., 2013). Some ssRNA(+)
viruses that are able to infect mammalian cells may have
evolved to utilize the ESCRT pathway for the release of viral
particle, although little is known about the cellular compartment
involved in the formation of the replication compartment in
these viruses.
Our systematic siRNA knockdown screen revealed that
TSG101, CHMP2/3, and CHMP4 proteins play essential roles
in flavivirus propagation. ALIX was identified by quantitative pro-
teomic analysis of purified replication organelles, but siRNA
knockdown of this factor did not reveal a role in flavivirus propa-
gation (Figures 1A and 1B). This may be explained by the in-
crease in the cytoplasmic level of ALIX in flavivirus-infected cells
(Pattanakitsakul et al., 2010), although it is possible that ALIX
may be partially or indirectly involved in flavivirus propagation
as previously shown by the inhibitory effects of its dominant-
negative forms (Carpp et al., 2011; Garg et al., 2013). The re-
quirements for ESCRT factors are similar to those of retroviral
budding, although retroviruses require the VPS4 family, but not
CHMP3 (Morita et al., 2011). These results suggest that viral
budding may be organized by common core machinery distinct
from that involved in cytokinesis orMVB vesicle formation. In this
mechanism, TSG101, an early acting ESCRT, is recruited to the
budding site on the ERmembrane and functions as an adaptor to
recruit downstream ESCRTs, the CHMP2/3 and CHMP4 pro-
teins. After the CHMP4 proteins form circular filaments inside
the neck, the CHMP2/3 family caps the filament and induces
membrane fission.2344 Cell Reports 16, 2339–2347, August 30, 2016TSG101 was identified as the most upstream factor among
ESCRT proteins utilized by flaviviruses, and, thus, it could play
a role in recruiting the whole ESCRT machinery to the viral
budding site. Our siRNA rescue experiments revealed that the
PT(/S)AP-binding function of TSG101 is important in flavivirus
infection (Figure 6A). To date, no PT(/S)AP viral late domains
have been identified in the viral genome, but a similar motif in
the viral sequence may play a critical role in viral particle forma-
tion. TSG101 interacts with viral NS3 proteins (Chiou et al., 2003).
Our extensive yeast two-hybrid screening confirmed this inter-
action, although the mapping experiments revealed that the
C-terminal head region of TSG101 was responsible for binding
to NS3 (Figure S4). The C-terminal head of TSG101 is highly
hydrophobic, and its crystal structure indicates that this whole
region is covered by other ESCRT-I subunits, VPS28 and
VPS37s (Kostelansky et al., 2007). Additional experiments will
be required to elucidate how TSG101 is recruited to the site of
viral particle formation.
One of the remarkable results from our screen is that the VPS4
family is not important to ESCRT-mediated processes in flavivi-
rus infection. Co-depletion of VPS4A and VPS4B did not have
any effect on flavivirus growth (Figures 1A and 1B). Furthermore,
re-expression of CHMP2A mutants that do not bind VPS4 family
proteins still rescued flavivirus propagation (Figure 6B). This is
the first evidence that a VPS4-independent ESCRT pathway
exists, and these results imply that other AAA-ATPases may
function in flavivirus infection in place of VPS4. We have not suc-
ceeded in identifying the factors involved in the disassembly of
ESCRT proteins, but other essential CHMP4-binding proteins,
such as the CC2D1 family, may contribute to the alternative
ESCRT pathway on the ER membrane.
In all of our experiments, we obtained similar results in both
JEV and DENV infection, suggesting that a unique set of ESCRT
requirements for viral infection may be a common feature of
genus Flavivirus. Further biochemical analysis of ESCRT-medi-
ated viral particle formation may contribute to the development
of common antiviral drugs that are effective against viruses in
this genus.EXPERIMENTAL PROCEDURES
Cells, Viruses, and Reagents
The 293A, 293T, BHK-21, and Vero cells were cultured in DMEM containing
10% fetal calf serum (FCS). JEV strain AT31 and DENV 2 strain NGC (ATCC
Figure 6. Unique Binding Requirements for ESCRT Proteins in Flavivirus Propagation
(A–E) Effects of expression of siRNA-resistant ESCRT mutants on viral propagation. The 293A cells co-transfected with control (lane 1 in each panel), TSG101
(lanes 2–6 in A), CHMP2A-B and CHMP3 (lanes 2–6 in B), or CHMP4A–C (lanes 2–6 in C–E) siRNA with various siRNA-resistant WT or mutant plasmids were
infected with JEV. Extracellular viral titers were measured 72 hr post-infection.
*p < 0.01 and **p < 0.05 relative to control siRNA; ns, non-significant. Mutants key: TSG101, Ub- (N45A or D46A); TSG101, PTAP- (M95A); TSG101, CEP55- (154-
164A); CHMP2A, VPS4- (L261D, L219D); CHMP2A, CHMP4- (R24A, R27A, R31A); CHMP2A,DN (missing eight N-terminal amino acids); CHMP4A, ALIX- (L260A);
CHMP4B, ALIX- (L217A); CHMP4C, ALIX- (L228A); CHMP4B, CC2D1A- (E90R, E94R, E97R).VR-1584) were grown in 293A and BHK-21 cells, respectively. The siRNAs,
expression vectors, and antibodies are shown in the Supplemental Experi-
mental Procedures.
siRNA Knockdown and Rescue Experiment
The 293A cells were transfected twice with 10 nM siRNA (Lipofectamine
RNAiMAX, Thermo Fisher Scientific) at 24-hr intervals, and viruses were
infected after an additional 24 hr. At 72 hr post-infection, viral titers in culture
supernatants were measured by focus-forming assay as described previously
(Katoh et al., 2013). For rescue experiments, siRNAsweremixedwith plasmids
and transfected with Lipofectamine 2000 (Thermo Fisher Scientific). To adjust
the level of exogenously expressed CHMP4A to match the level of endoge-nous CHMP4A, we used the D3CMV-attenuated promoter expression system
(Morita et al., 2012).
Viral Genomic RNA Transfection and SRIP Production
For infectious RNA transfection experiments, siRNA-transfected 293T cells
were incubated for 24 hr, co-transfected a second time with the same
siRNAs together with in-vitro-transcribed RNA from rJEV (Mie/41/2002)/
pMW119 (kindly provided by Dr. Shigeru Tajima), and incubated for the indi-
cated times. For SRIP production experiments, 293T cells were co-transfected
with pCMV-JErep and pCAG-JECE as reported previously (Suzuki et al.,
2014). Virus- or SRIP-containing supernatants were harvested and monitored
for infectivity (see also the Supplemental Experimental Procedures).Cell Reports 16, 2339–2347, August 30, 2016 2345
Immunoelectron Microscopy
The pre-embedding gold enhancement immunogold method was performed
as described previously (Gibbings et al., 2009) (see the Supplemental Experi-
mental Procedures for details).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
four figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2016.07.068.
AUTHOR CONTRIBUTIONS
K.T. was responsible for all siRNA depletion experiments, analyzed and inter-
preted data, and wrote the manuscript. M. Arimoto, M. Arakawa, and A.A.
helped with siRNA screening. A.N. and H.O. performed electron microscopy
studies. K.S. performed mass spectrometry analysis. T.I., E.K., and R.S.
generated viral trans-packaging system. Y.M. established sub-viral replicon
cell line. K.T. and E.M. conceived and coordinated the study, interpreted the
findings, and wrote the manuscript.
ACKNOWLEDGMENTS
We thank Dr. Shigeru Tajima for the gift of plasmid rJEV (Mie/41/2002)/
pMW119 and Dr. Wesley I. Sundquist for ESCRT plasmids and antibodies.
This research was supported by the Japan Society for the Promotion of Sci-
ence (JSPS) KAKENHI grants (23790503, 26460555, and 16H01188), a Health
Labor Sciences Research Grant for Research on Emerging and Re-emerging
Infectious Diseases (12103320), the Uehara Memorial Foundation, the Cell
Science Research Foundation, and the Naito Foundation.
Received: March 16, 2016
Revised: July 5, 2016
Accepted: July 25, 2016
Published: August 18, 2016
REFERENCES
Barajas, D., Jiang, Y., and Nagy, P.D. (2009). A unique role for the host ESCRT
proteins in replication of Tomato bushy stunt virus. PLoS Pathog. 5, e1000705.
Buchkovich, N.J., Henne, W.M., Tang, S., and Emr, S.D. (2013). Essential
N-terminal insertion motif anchors the ESCRT-III filament during MVB vesicle
formation. Dev. Cell 27, 201–214.
Carlton, J.G., and Martin-Serrano, J. (2007). Parallels between cytokinesis
and retroviral budding: a role for the ESCRT machinery. Science 316, 1908–
1912.
Carlton, J.G., Caballe, A., Agromayor, M., Kloc, M., and Martin-Serrano, J.
(2012). ESCRT-III governs the Aurora B-mediated abscission checkpoint
through CHMP4C. Science 336, 220–225.
Carpp, L.N., Galler, R., and Bonaldo, M.C. (2011). Interaction between the yel-
low fever virus nonstructural protein NS3 and the host protein Alix contributes
to the release of infectious particles. Microbes Infect. 13, 85–95.
Chatel-Chaix, L., and Bartenschlager, R. (2014). Dengue virus- and hepatitis
C virus-induced replication and assembly compartments: the enemy inside–
caught in the web. J. Virol. 88, 5907–5911.
Chiou, C.-T., Hu, C.-C.A., Chen, P.-H., Liao, C.-L., Lin, Y.-L., and Wang, J.-J.
(2003). Association of Japanese encephalitis virus NS3 protein with microtu-
bules and tumour susceptibility gene 101 (TSG101) protein. J. Gen. Virol. 84,
2795–2805.
Corless, L., Crump, C.M., Griffin, S.D.C., and Harris, M. (2010). Vps4 and the
ESCRT-III complex are required for the release of infectious hepatitis C virus
particles. J. Gen. Virol. 91, 362–372.
Diaz, A., Zhang, J., Ollwerther, A., Wang, X., and Ahlquist, P. (2015). Host
ESCRT proteins are required for bromovirus RNA replication compartment as-
sembly and function. PLoS Pathog. 11, e1004742.2346 Cell Reports 16, 2339–2347, August 30, 2016Effantin, G., Dordor, A., Sandrin, V., Martinelli, N., Sundquist, W.I., Schoehn,
G., and Weissenhorn, W. (2013). ESCRT-III CHMP2A and CHMP3 form vari-
able helical polymers in vitro and act synergistically during HIV-1 budding.
Cell. Microbiol. 15, 213–226.
Feng, Z., Hensley, L., McKnight, K.L., Hu, F., Madden, V., Ping, L., Jeong,
S.-H., Walker, C., Lanford, R.E., and Lemon, S.M. (2013). A pathogenic picor-
navirus acquires an envelope by hijacking cellular membranes. Nature 496,
367–371.
Garg, H., Lee, R.T.C., Tek, N.O., Maurer-Stroh, S., and Joshi, A. (2013). Iden-
tification of conserved motifs in the West Nile virus envelope essential for par-
ticle secretion. BMC Microbiol. 13, 197.
Gibbings, D.J., Ciaudo, C., Erhardt, M., and Voinnet, O. (2009). Multivesicular
bodies associate with components of miRNA effector complexes and modu-
late miRNA activity. Nat. Cell Biol. 11, 1143–1149.
Gould, E.A., and Solomon, T. (2008). Pathogenic flaviviruses. Lancet 371,
500–509.
Henne, W.M., Buchkovich, N.J., and Emr, S.D. (2011). The ESCRT pathway.
Dev. Cell 21, 77–91.
Hurley, J.H., and Hanson, P.I. (2010). Membrane budding and scission
by the ESCRT machinery: it’s all in the neck. Nat. Rev. Mol. Cell Biol. 11,
556–566.
Hurley, J.H., Boura, E., Carlson, L.-A., and Ro´ _zycki, B. (2010). Membrane
budding. Cell 143, 875–887.
Katoh, H., Okamoto, T., Fukuhara, T., Kambara, H., Morita, E., Mori, Y., Kami-
tani, W., and Matsuura, Y. (2013). Japanese encephalitis virus core protein
inhibits stress granule formation through an interaction with Caprin-1 and facil-
itates viral propagation. J. Virol. 87, 489–502.
Kostelansky, M.S., Schluter, C., Tam, Y.Y.C., Lee, S., Ghirlando, R., Beach, B.,
Conibear, E., and Hurley, J.H. (2007). Molecular architecture and functional
model of the complete yeast ESCRT-I heterotetramer. Cell 129, 485–498.
Martinelli, N., Hartlieb, B., Usami, Y., Sabin, C., Dordor, A., Miguet, N., Avilov,
S.V., Ribeiro, E.A., Jr., Go¨ttlinger, H., and Weissenhorn, W. (2012). CC2D1A is
a regulator of ESCRT-III CHMP4B. J. Mol. Biol. 419, 75–88.
McCullough, J., Fisher, R.D., Whitby, F.G., Sundquist, W.I., and Hill, C.P.
(2008). ALIX-CHMP4 interactions in the human ESCRT pathway. Proc. Natl.
Acad. Sci. USA 105, 7687–7691.
McCullough, J., Colf, L.A., and Sundquist, W.I. (2013). Membrane fission reac-
tions of the mammalian ESCRT pathway. Annu. Rev. Biochem. 82, 663–692.
Morita, E. (2012). Differential requirements of mammalian ESCRTs in multive-
sicular body formation, virus budding and cell division. FEBS J. 279, 1399–
1406.
Morita, E., Sandrin, V., Chung, H.-Y., Morham, S.G., Gygi, S.P., Rodesch,
C.K., and Sundquist, W.I. (2007). Human ESCRT and ALIX proteins interact
with proteins of the midbody and function in cytokinesis. EMBO J. 26, 4215–
4227.
Morita, E., Colf, L.A., Karren, M.A., Sandrin, V., Rodesch, C.K., and Sundquist,
W.I. (2010). Human ESCRT-III and VPS4 proteins are required for centrosome
and spindle maintenance. Proc. Natl. Acad. Sci. USA 107, 12889–12894.
Morita, E., Sandrin, V., McCullough, J., Katsuyama, A., Baci Hamilton, I., and
Sundquist, W.I. (2011). ESCRT-III protein requirements for HIV-1 budding. Cell
Host Microbe 9, 235–242.
Morita, E., Arii, J., Christensen, D., Votteler, J., and Sundquist, W.I. (2012).
Attenuated protein expression vectors for use in siRNA rescue experiments.
Biotechniques 0, 1–5.
Olmos, Y., Hodgson, L., Mantell, J., Verkade, P., and Carlton, J.G. (2015).
ESCRT-III controls nuclear envelope reformation. Nature 522, 236–239.
Pattanakitsakul, S.-N., Poungsawai, J., Kanlaya, R., Sinchaikul, S., Chen,
S.-T., and Thongboonkerd, V. (2010). Association of Alix with late endosomal
lysobisphosphatidic acid is important for dengue virus infection in human
endothelial cells. J. Proteome Res. 9, 4640–4648.
Pornillos, O., Alam, S.L., Davis, D.R., and Sundquist, W.I. (2002). Structure
of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6
protein. Nat. Struct. Biol. 9, 812–817.
Porter, K.R., and MacHado, R.D. (1960). Studies on the endoplasmic reticu-
lum. IV. Its form and distribution during mitosis in cells of onion root tip.
J. Biophys. Biochem. Cytol. 7, 167–180.
Stuchell-Brereton,M.D., Skalicky, J.J., Kieffer, C., Karren, M.A., Ghaffarian, S.,
and Sundquist, W.I. (2007). ESCRT-III recognition by VPS4 ATPases. Nature
449, 740–744.
Suzuki, R., Ishikawa, T., Konishi, E., Matsuda, M., Watashi, K., Aizaki, H., Ta-
kasaki, T., and Wakita, T. (2014). Production of single-round infectious
chimeric flaviviruses with DNA-based Japanese encephalitis virus replicon.
J. Gen. Virol. 95, 60–65.Vietri, M., Schink, K.O., Campsteijn, C., Wegner, C.S., Schultz, S.W., Christ, L.,
Thoresen, S.B., Brech, A., Raiborg, C., and Stenmark, H. (2015). Spastin
and ESCRT-III coordinate mitotic spindle disassembly and nuclear envelope
sealing. Nature 522, 231–235.
Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C.K.E.,Walther, P., Ful-
ler, S.D., Antony, C., Krijnse-Locker, J., and Bartenschlager, R. (2009).
Composition and three-dimensional architecture of the dengue virus replica-
tion and assembly sites. Cell Host Microbe 5, 365–375.
Yamazaki, Y., Takahashi, T., Hiji, M., Kurashige, T., Izumi, Y., Yamawaki, T.,
and Matsumoto, M. (2010). Immunopositivity for ESCRT-III subunit CHMP2B
in granulovacuolar degeneration of neurons in the Alzheimer’s disease hippo-
campus. Neurosci. Lett. 477, 86–90.Cell Reports 16, 2339–2347, August 30, 2016 2347
